Experienced in Scleroderma

Kyung-su R. Park

St. Vincent's Hospital, 
Suwon, KR 
Experienced in Scleroderma
St. Vincent's Hospital, 
Suwon, KR 
OverviewLocationsClinical Research

Overview

Kyung-su Park practices in Suwon, Republic of Korea. Park is rated as an Experienced expert by MediFind in the treatment of Scleroderma. Their top areas of expertise are Arthritis, Rheumatoid Arthritis (RA), Ankylosing Spondylitis, and Jones Syndrome.

Their clinical research consists of co-authoring 79 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Scleroderma.

Locations

St. Vincent's Hospital, Suwon, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3

79 Total Publications

Corrigendum to 'Compendium of Skin Molecular Signatures Identifies Key Pathologic Features Associated with Fibrosis in Systemic Sclerosis' Ann Rheum Dis. 2019;78:817-825.
Corrigendum to 'Compendium of Skin Molecular Signatures Identifies Key Pathologic Features Associated with Fibrosis in Systemic Sclerosis' Ann Rheum Dis. 2019;78:817-825.
Journal: Annals of the rheumatic diseases
Published: June 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Park's expertise for a condition
ConditionClose
      View All 20 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile